1-6 of 6
Susana Carvalho
Close
Sort by
Journal Articles

Safety Profile of Idelalisib in Patients with Refractory Follicular Lymphoma: Interim Analysis of a Noninterventional Study

Gilles Salles, MD PhD, Ka Lung Wu, MD PhD, Sofya Kovalchuk, MD, Santiago Mercadal, MD, Annalisa Chiarenza, MD PhD, Ruth Pettengell, MD, Elisabeth Vandenberghe, MD, Paolo Corradini, MD, Susana Carvalho, MD, Christophe De Belder, MSc, Rikisha Shah Gupta, MPH, Anna van Troostenburg, MD, Nishanthan Rajakumaraswamy, MD, Heribert Ramroth, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 48–50.
https://doi.org/10.1182/blood-2020-137607
Published: 2020
Journal Articles

Consolidation Treatment with VRD Followed By Maintenance Therapy Versus Maintenance Alone in Newly Diagnosed, Transplant-Eligible Patients with Multiple Myeloma (MM): A Randomized Phase 3 Trial of the European Myeloma Network (EMN02/HO95)

Pieter Sonneveld, MD PhD, Meral Beksac, MD, Bronno Van Der Holt, PhD, Meletios A Dimopoulos, Angelo Michele Carella, MD, Heinz Ludwig, MD, Sonja Zweegman, MD PhD, Thilo Zander, MD, Ruth Wester, MD, Roman Hajek, MD, Lucia Pantani, MD PhD, Luca Dozza, MSc, Francesca Gay, MD, Anna Maria Cafro, Luca De Rosa, Francesca Fioritoni, MD, Ulf-Henrik Mellqvist, MD PhD, Rossella Troia, PharmD, Niels Frost Andersen, MD PhD, Ka Lung Wu, MD PhD, Christoph Driessen, MD, Susana Carvalho, MD, Alexandra J. Croockewit, MD PhD, Fredrik Schjesvold, MDPhD, Massimo Offidani, Michele Cavo, Mario Boccadoro
Journal: Blood
Blood (2020) 136 (Supplement 1): 46–48.
https://doi.org/10.1182/blood-2020-139337
Published: 2020
Journal Articles

"Real-World" Peripheral T-Cell Lymphomas Experience in Portugal: Is There Reason for Optimism?

Ivan Dlouhy, Rita Gavancha, MD, Inês Coelho, MD, Catalina Gomez, MD, Inês Barbosa, MD, Susana Carvalho, MD, Maria Ceu Trindade, MD, Ana Filipa Moita, Gonçalo Esteves, MD, Paula Gameiro, Jose Cabecadas, Maria Silva, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5287.
https://doi.org/10.1182/blood-2019-124485
Published: 2019
Journal Articles

Bortezomib-Based Therapy Overcomes the Adverse Impact of Renal Impairment in Transplant Eligible Patients: An Analysis of the Prospective Randomized EMN02/HO95 Study

Meletios A. Dimopoulos, Efstathios Kastritis, Roman Hajek, Luca Dozza, Meral Beksac, MD, Alessandra Larocca, Hans Erik Johnsen, MD Professor, Ulf-Henrik Mellqvist, MD, Anders Waage, MD PhD, Sonja Zweegman, MD PhD, Heinz Ludwig, MD, Lucia Pantani, MD, Andrew Spencer, MD, Anna Pascarella, Marina Martello, Susana Carvalho, Hlif Steingrimsdottir, MD, Claudia Cellini, MD, Petra Cornelisse, Rossella Troia, Patrizia Tosi, MD, Bronno van der Holt, Mario Boccadoro, Pieter Sonneveld, MDPhD, Michele Cavo, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4545.
https://doi.org/10.1182/blood.V130.Suppl_1.4545.4545
Published: 2017
Journal Articles

The NCCN-IPI Helps to Identify Very High-Risk Patients with DLBCL and Can be Improved By Other Independent Clinical Factors Including Bulky Disease and beta2-Microglobulin

Rita Coutinho, MD PhD, Joana Lobato, MD, Susana Esteves, Susana Carvalho, MD, Francesca Pierdomenico, MD, Paulo Bernardo, MD, Filipe Gonçalves, MD, Joana Desterro, MD, Soraia Martins, Carla Silva, Maria Gomes Silva, MD PhD
Journal: Blood
Blood (2015) 126 (23): 3888.
https://doi.org/10.1182/blood.V126.23.3888.3888
Published: 2015
Journal Articles

Health Outcomes and Costs of Rituximab in Combination with Cyclophosphamide, Vincristine and Prednisolone in the Treatment of Patients with Advanced Follicular Lymphoma in Portugal.

Paula Braga, Susana Carvalho, Marília Gomes, Lurdes Guerra, Paulo Lúcio, Herlander Marques, Filipa Negreiro, Statistician, Catarina Pereira, Catarina Silva, Senior, Statistician, Adriana Teixeira
Journal: Blood
Blood (2009) 114 (22): 2481.
https://doi.org/10.1182/blood.V114.22.2481.2481
Published: 2009